TAO Synergies Inc. (TAOX)
NASDAQ: TAOX · Real-Time Price · USD
5.99
-0.68 (-10.19%)
At close: Dec 5, 2025, 4:00 PM EST
6.26
+0.27 (4.51%)
After-hours: Dec 5, 2025, 7:51 PM EST
Company Description
TAO Synergies Inc. owns and operates an AI token. The company executes a cryptocurrency treasury strategy centered on the acquisition and staking of the TAO token, the native utility token of the Bittensor network.
TAO Synergies Inc. was formerly known as Synaptogenix, Inc. and changed its name to TAO Synergies Inc. in June 2025.
The company was incorporated in 2012 and is headquartered in New York, New York.
TAO Synergies Inc.
| Country | United States |
| Founded | 2012 |
| Industry | Software - Infrastructure |
| Sector | Technology |
| Employees | 4 |
Contact Details
Address: 1185 Avenue of the Americas, 3rd Floor New York, New York 10036 United States | |
| Phone | 973 242 0005 |
| Website | taosynergies.com |
Stock Details
| Ticker Symbol | TAOX |
| Exchange | NASDAQ |
| Stock Type | Common Stock |
| Fiscal Year | January - December |
| Reporting Currency | USD |
| CIK Code | 0001571934 |
| ISIN Number | US87167T3005 |
| Employer ID | 46-1585656 |
| SIC Code | 6199 |
Key Executives
| Name | Position |
|---|---|
| Joshua N. Silverman | Executive Chairman of the Board |
| Dr. Daniel L. Alkon M.D. | President and Director |
| Robert Weinstein | Chief Financial Officer, Executive Vice President, Treasurer and Secretary |
| Dr. Alan J. Tuchman M.D., MBA(FAAN) | Chief Medical Officer |
Latest SEC Filings
| Date | Type | Title |
|---|---|---|
| Nov 21, 2025 | EFFECT | Notice of Effectiveness |
| Nov 17, 2025 | DEF 14A | Other definitive proxy statements |
| Nov 17, 2025 | ARS | Filing |
| Nov 14, 2025 | 10-Q | Quarterly Report |
| Nov 12, 2025 | S-3 | Registration statement under Securities Act of 1933 |
| Nov 7, 2025 | PRE 14A | Other preliminary proxy statements |
| Oct 24, 2025 | D | Notice of Exempt Offering of Securities |
| Oct 14, 2025 | 8-K | Current Report |
| Aug 29, 2025 | 8-K | Current Report |
| Aug 14, 2025 | S-8 | Securities to be offered to employees in employee benefit plans |